Abstract
Relevance. Cardiogenic shock remains the most common cause of death in myocardial infarction. Aim. To evaluate the myocardial infarction complicated by cardiogenic shock clinical course features in males under 50 years old (y.o.) to clarify their significance for the development of this complication to improve prevention and outcomes. Material and methods. The study included males aged 19-49 y.o. with type I myocardial infarction. The patients were divided into age-matched groups. The study group consisted of seven patients with cardiogenic shock, the control group - without cardiogenic shock - 223 patients. Comparative analysis of the clinical course variants, complications in selected groups was performed. The influence of the studied parameters on the probability of cardiogenic shock development in the examined patients was assessed by the method of risk analysis using the Pearson Chi-square test. Results. In the study group, there was a predominance of kidney dysfunction (100 in the study group and 10.3% in the control group; p=0.004), chronic heart failure in history less than one year old (50.0 and 15.3%, respectively; p=0, 04), non-anginal variants (abdominal (16.7 and 1.5%; p = 0.0497), arrhythmic (16.7 and 2.5% p = 0.0497) and according to the type of increase in heart failure (16.7 and 1.5%; p=0.0497)) of the clinical course of myocardial infarction, the presence of two or more complications (100 and 38.1%; p=0.005) and combinations of all groups of myocardial lesions (57.1 and 6.3% ; р˂0.0001). The risk of developing cardiogenic shock increased in addition to the above situations with diastolic blood pressure ˂70 mm Hg (Absolute risk: 18.8%; relative: 13.3; p˂0.0001), systolic˂110 mmHg (14.3%; 9.9, respectively; p=0.0004), total peripheral resistance (37.5%; 35.8; p˂0.0001). Conclusions. These factors should be used in the formation of high-risk groups for the cardiogenic shock in myocardial infarction development for monitoring and timely implementation of the necessary treatment. It is also expedient to take them into account in the prognostic modeling of this complication.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.